These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 22507876)

  • 1. Similar risk of renal events among patients treated with tenofovir or entecavir for chronic hepatitis B.
    Gish RG; Clark MD; Kane SD; Shaw RE; Mangahas MF; Baqai S
    Clin Gastroenterol Hepatol; 2012 Aug; 10(8):941-6; quiz e68. PubMed ID: 22507876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term efficacy and safety of lamivudine, entecavir, and tenofovir for treatment of hepatitis B virus-related cirrhosis.
    Köklü S; Tuna Y; Gülşen MT; Demir M; Köksal AŞ; Koçkar MC; Aygün C; Coban S; Ozdil K; Ataseven H; Akin E; Pürnak T; Yüksel I; Ataseven H; Ibiş M; Yildirim B; Nadir I; Küçükazman M; Akbal E; Yüksel O; Başar O; Alkan E; Baykal O
    Clin Gastroenterol Hepatol; 2013 Jan; 11(1):88-94. PubMed ID: 23063679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency and risk factors of renal impairment during long-term adefovir dipivoxil treatment in chronic hepatitis B patients.
    Kim YJ; Cho HC; Sinn DH; Gwak GY; Choi MS; Koh KC; Paik SW; Yoo BC; Lee JH
    J Gastroenterol Hepatol; 2012 Feb; 27(2):306-12. PubMed ID: 21777281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-line monotherapies of tenofovir and entecavir have comparable efficacies in hepatitis B treatment.
    Ozaras R; Mete B; Ceylan B; Ozgunes N; Gunduz A; Karaosmanoglu H; Cagatay A; Gokturk K; Erdem L; Kocak F; Senates E; Tabak F
    Eur J Gastroenterol Hepatol; 2014 Jul; 26(7):774-80. PubMed ID: 24901822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Entecavir plus tenofovir combination as rescue therapy in pre-treated chronic hepatitis B patients: an international multicenter cohort study.
    Petersen J; Ratziu V; Buti M; Janssen HL; Brown A; Lampertico P; Schollmeyer J; Zoulim F; Wedemeyer H; Sterneck M; Berg T; Sarrazin C; Lutgehetmann M; Buggisch P
    J Hepatol; 2012 Mar; 56(3):520-6. PubMed ID: 22037226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of HBV polymerase inhibitors on renal function in patients with chronic hepatitis B.
    Mauss S; Berger F; Filmann N; Hueppe D; Henke J; Hegener P; Athmann C; Schmutz G; Herrmann E
    J Hepatol; 2011 Dec; 55(6):1235-40. PubMed ID: 21703180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of renal safety and efficacy of telbivudine, entecavir and tenofovir treatment in chronic hepatitis B patients: real world experience.
    Tsai MC; Chen CH; Tseng PL; Hung CH; Chiu KW; Wang JH; Lu SN; Lee CM; Chang KC; Yen YH; Lin MT; Chou YP; Hu TH
    Clin Microbiol Infect; 2016 Jan; 22(1):95.e1-95.e7. PubMed ID: 26055419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nephrotoxicity caused by oral antiviral agents in patients with chronic hepatitis B treated in a hospital for tropical diseases in Thailand.
    Thu AM; Poovorawan K; Kittitrakul C; Nontprasert A; Sriboonvorakul N; Phumratanaprapin W; Tangkijvanich P; Leowattana W; Wilairatana P
    BMC Pharmacol Toxicol; 2015 Dec; 16():38. PubMed ID: 26651337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal Function in Chronic Hepatitis B Patients Treated With Tenofovir Disoproxil Fumarate or Entecavir Monotherapy: A Matched Case-Cohort Study.
    Ha NB; Ku K; Ha NB; Chaung KT; Trinh HN; Nguyen MH
    J Clin Gastroenterol; 2015; 49(10):873-7. PubMed ID: 25856383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tenofovir-induced Fanconi syndrome in chronic hepatitis B monoinfected patients that reverted after tenofovir withdrawal.
    Viganò M; Brocchieri A; Spinetti A; Zaltron S; Mangia G; Facchetti F; Fugazza A; Castelli F; Colombo M; Lampertico P
    J Clin Virol; 2014 Dec; 61(4):600-3. PubMed ID: 25453573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in Renal Function in Patients With Chronic HBV Infection Treated With Tenofovir Disoproxil Fumarate vs Entecavir.
    Trinh S; Le AK; Chang ET; Hoang J; Jeong D; Chung M; Lee MH; Wang U; Henry L; Cheung R; Nguyen MH
    Clin Gastroenterol Hepatol; 2019 Apr; 17(5):948-956.e1. PubMed ID: 30130625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal dysfunction in chronic hepatitis B patients treated with adefovir dipivoxil.
    Ha NB; Ha NB; Garcia RT; Trinh HN; Vu AA; Nguyen HA; Nguyen KK; Levitt BS; Nguyen MH
    Hepatology; 2009 Sep; 50(3):727-34. PubMed ID: 19517525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telbivudine improves renal function in patients with chronic hepatitis B.
    Gane EJ; Deray G; Liaw YF; Lim SG; Lai CL; Rasenack J; Wang Y; Papatheodoridis G; Di Bisceglie A; Buti M; Samuel D; Uddin A; Bosset S; Trylesinski A
    Gastroenterology; 2014 Jan; 146(1):138-146.e5. PubMed ID: 24067879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of entecavir, tenofovir and telbivudine treatment on renal functions in chronic hepatitis B patients.
    Kara AV; Yıldırım Y; Ozcicek F; Aldemir MN; Arslan Y; Bayan K; Çelen MK
    Acta Gastroenterol Belg; 2019; 82(2):273-277. PubMed ID: 31314188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early kidney injury during long-term adefovir dipivoxil therapy for chronic hepatitis B.
    Jia HY; Ding F; Chen JY; Lian JS; Zhang YM; Zeng LY; Xiang DR; Yu L; Hu JH; Yu GD; Cai H; Lu YF; Zheng L; Li LJ; Yang YD
    World J Gastroenterol; 2015 Mar; 21(12):3657-62. PubMed ID: 25834334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of nucleoside and nucleotide analogues on renal function in patients with chronic hepatitis B virus monoinfection.
    Mallet V; Schwarzinger M; Vallet-Pichard A; Fontaine H; Corouge M; Sogni P; Pol S
    Clin Gastroenterol Hepatol; 2015 Jun; 13(6):1181-8.e1. PubMed ID: 25460550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of glomerular filtration rate in HIV-infected, HIV-HBV-coinfected and HBV-infected patients receiving tenofovir disoproxil fumarate.
    Pradat P; Le Pogam MA; Okon JB; Trolliet P; Miailhes P; Brochier C; Maynard M; Bailly F; Zoulim F; Cotte L
    J Viral Hepat; 2013 Sep; 20(9):650-7. PubMed ID: 23910650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment Outcome and Renal Safety of 3-Year Tenofovir Disoproxil Fumarate Therapy in Chronic Hepatitis B Patients with Preserved Glomerular Filtration Rate.
    Min IS; Lee CH; Shin IS; Lee NE; Son HS; Kim SB; Seo SY; Kim SH; Kim SW; Lee SO; Lee ST; Kim IH
    Gut Liver; 2019 Jan; 13(1):93-103. PubMed ID: 30400723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term Nucleotide Analogue Treatment Has Higher Levels of Renal Toxicities than Does Entecavir in Patients with Chronic Hepatitis B.
    Cho YY; Chang Y; Nam JY; Cho H; Cho EJ; Lee JH; Yu SJ; Yoon JH; Kim YJ
    Gut Liver; 2020 Mar; 14(2):225-231. PubMed ID: 31060115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High rate of reversibility of renal damage in a cohort of HIV-infected patients receiving tenofovir-containing antiretroviral therapy.
    Bonjoch A; Echeverría P; Perez-Alvarez N; Puig J; Estany C; Clotet B; Negredo E
    Antiviral Res; 2012 Oct; 96(1):65-9. PubMed ID: 22892171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.